Reduction of Immunosuppression as Initial Therapy for Posttransplantation Lymphoproliferative Disorder★

Multicenter Analysis of 80 Solid Organ Transplantation Recipients With Post-Transplantation Lymphoproliferative Disease: Outcomes and Prognostic Factors in the Modern Era

(2010) Andrew M. Evens et al.   JOURNAL OF CLINICAL ONCOLOGY

Posttransplant Lymphoproliferative Disorder Following Pancreas Transplantation

(2009) N. Issa et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Lymphoma After Solid Organ Transplantation: Risk, Response to Therapy, and Survival at a Transplantation Center

(2009) Jason S. Knight et al.   JOURNAL OF CLINICAL ONCOLOGY

Prospective Study of Sequential Reduction in Immunosuppression, Interferon Alpha-2B, and Chemotherapy for Posttransplantation Lymphoproliferative Disorder

(2009) Lode J. Swinnen et al.   TRANSPLANTATION

Post-Transplant Lymphoproliferative Disorders after Heart or Kidney Transplantation at a Single Centre: Presentation and Response to Treatment

(2008) S.M.L. Aversa et al.   ACTA HAEMATOLOGICA

EBV PCR in the Diagnosis and Monitoring of Posttransplant Lymphoproliferative Disorder: Results of a Two-Arm Prospective Trial

(2008) D. E. Tsai et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Monoclonal Antibody Therapy for B-Cell Non-Hodgkin's Lymphoma

(2008) Bruce D. Cheson et al.   NEW ENGLAND JOURNAL OF MEDICINE